Subepithelial lesions (SLEs) are often detected incidentally during endoscopic examination. They represent a heterogeneous group of lesions including non-neoplastic and neoplastic lesion, the most ...

and histology-guided surveillance and treatment of individuals with Barrett's oesophagus, have considerable limitations. Barrett's oesophagus rarely progresses to oesophageal adenocarcinoma ...

and esophageal histology were utilized. Thereafter, three of the five patients responded to therapy for GER; two did not. The Bernstein test proved to have greater diagnostic reliability than any ...

Finding genetic, esophageal impedance signs or other biomarkers that can reliably identify the acute and recurrent stages of the disease are still an unmet need. In the meantime concordance on ...

In an attempt to minimize the risk of publication bias, conference abstracts and proceedings were searched through Web of Science, Embase and Scopus using the terms o/esophagus* and p53 ... patient ...

Objective: To evaluate the role of chromohysteroscopy in improving diagnostic accuracy of endometrial biopsy in cases of AUB. Design: Cross sectional interventional study. Materials and Methods: This ...

An expert review provides best practice advice on diagnostic considerations of immune-mediated disorders that should be ...

In such patients, the lower oesophageal sphincter muscle (which acts as a door between the stomach and the oesophagus) doesn’t work properly, allowing acid to move up from the stomach into the ...

This disease affects the oesophagus - the tube connecting your mouth to your stomach. It is an especially dangerous form of cancer, ranking as the 14th most common in the UK but causing the ...

Eosinophilic esophagitis (EoE) occurs when white blood cells called eosinophils build up in the esophagus, the tube that moves food and liquids from the throat to the stomach. This buildup of ...

Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 5-year (y) follow-up ...